For example, previous studies have demonstrated that USP39 plays a role in carboplatin resistance in ovarian cancer and in regulating chemoresistance to cisplatin by stabilizing CHK2 in human lung cancer cells (40, 90). Here, USP39 is linked to ovarian cancer.